Form 8-K - Current report:
SEC Accession No. 0001193125-16-699650
Filing Date
2016-09-01
Accepted
2016-09-01 16:24:02
Documents
3
Period of Report
2016-08-31
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d219216d8k.htm 8-K 24837
2 EX-99.1 d219216dex991.htm EX-99.1 11003
3 GRAPHIC g219216g88m02.jpg GRAPHIC 10533
  Complete submission text file 0001193125-16-699650.txt   51749
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108 801-584-3600
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-26642 | Film No.: 161866039
SIC: 2835 In Vitro & In Vivo Diagnostic Substances